Efficacy data on teriparatide (parathyroid hormone) in patients with postmenopausal osteoporosis

By Debiais F.  

Joint Bone Spine, Vol. 70, Iss. 6, 2003-12 ,pp. : 465-470

Elsevier

Access to resources Recommend Favorite

The Relationship between Apelin and Parathyroid Hormone in Hemodialysis Patients

By Mafra Denise   Lobo Julie C.   Farage Najla E.   Stockler-Pinto Milena B.   Leal Viviane O.   Calixto Antonio   Geloneze Bruno  

Renal Failure, Vol. 34, Iss. 8, 2012-09 ,pp. : 970-973

Informa Healthcare

Access to resources Recommend Favorite

Effect and safety of intermittent weekly administration of human parathyroid hormone 1-34 in patients with primary osteoporosis evaluated by histomorphometry and microstructural analysis of iliac trabecular bone before and after 1 year of treatment

By Miki Takami   Nakatsuka Kiyoshi   Naka Hiroshi   Masaki Hideki   Imanishi Yasuo   Ito Masako   Inaba Masaaki   Morii Hirotoshi   Nishizawa Yoshiki  

Journal of Bone and Mineral Metabolism, Vol. 22, Iss. 6, 2004-11 ,pp. : 569-576

Springer Publishing Company

Access to resources Recommend Favorite

Increase of Bone Resorption and the Parathyroid Hormone in Postmenopausal Women in the Long-term after Roux-en-Y Gastric Bypass

By Valderas Juan   Velasco Soledad   Solari Sandra   Liberona Yessica   Viviani Paola   Maiz Alberto   Escalona Alex   González Gilberto  

Obesity Surgery, Vol. 19, Iss. 8, 2009-08 ,pp. : 1132-1138

Springer Publishing Company

Access to resources Recommend Favorite

Suppression of parathyroid hormone secretion in CAPD patients by intraperitoneal administration of Maxacalcitol

By Murakami Kazutaka   Miyachi Hiromi   Watanabe Asako   Kawamura Nahoko   Fujii Mikiko   Koide Shigehisa   Murase Masamitsu   Kushimoto Hiroko   Hasegawa Midori   Tomita Makoto   Hiki Yoshiyuki   Sugiyama Satoshi  

Clinical and Experimental Nephrology, Vol. 8, Iss. 2, 2004-06 ,pp. : 134-138

Springer Publishing Company

Access to resources Recommend Favorite